NCT07063420 Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
| NCT ID | NCT07063420 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Daniel Chernavvsky, MD |
| Condition | Type 2 Diabetes Treated With Insulin |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2025-10-28 |
| Primary Completion | 2026-07-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Eligibility Criteria
Inclusion Criteria: 1. Age ≥18.0 years old at time of consent. 2. Clinical diagnosis, based on investigator assessment, of type 2 diabetes for at least 6 months. 3. Hemoglobin A1c (HbA1c) ≥ 7.0%. 4. Currently using an approved long-acting insulin for at least 3 months (e.g., insulin glargine, insulin degludec). 5. Treated or about to be treated with multi-drug therapies for T2D. 6. If using a CGM, willingness to wear an additional study CGM during the duration of the study. 7. Access to the internet and willingness to upload data during the study as needed. 8. If female and sexually active, must agree to use a form of contraception to prevent pregnancy while a participant in the study. A negative serum or urine pregnancy test will be required for all females who self-report that they are of childbearing potential. Participants who become pregnant will be discontinued from the study. Also, participants who during the study develop and express the intention to become pregnant within the
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.